VOR: Vor Biopharma Inc. Stock

by  •  • Comments Off on VOR: Vor Biopharma Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 61.37
Enterprise Value ($M) 8.58
Book Value ($M) 72.95
Book Value / Share 1.07
Price / Book 0.84
NCAV ($M) 24.26
NCAV / Share 0.35
Price / NCAV 2.53

Profitability (mra)
Return on Invested Capital (ROIC) -1.06
Return on Assets (ROA) -0.50
Return on Equity (ROE) -0.64

Liquidity (mrq)
Quick Ratio 4.69
Current Ratio 4.69

Balance Sheet (mrq) ($M)
Current Assets 67.30
Assets 115.99
Liabilities 43.04
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
3 days ago 13G/A Paradigm Biocapital Advisors LP 0.00 -100.00
02-14 13D/A 5AM Ventures VI, L.P. 9.40 -4.94
02-09 13G/A Fmr Llc 11.24 -4.41

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A Amendment No. 1 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 117,896 374,563 31.48
2024-11-14 110,222 364,883 30.21
2024-11-13 196,711 528,880 37.19
2024-11-12 160,525 432,350 37.13
2024-11-11 400,961 1,243,172 32.25

(click for more detail)

Similar Companies
VERV – Verve Therapeutics, Inc. VIGL – Vigil Neuroscience, Inc.
VIR – Vir Biotechnology, Inc. VRTX – Vertex Pharmaceuticals Incorporated
VTRS – Viatris Inc.


Financial data and stock pages provided by
Fintel.io